July 16, 2021 This Week in Cardiology Podcast


Manage episode 297650129 series 2291284
Player FM과 저희 커뮤니티의 Medscape Podcasts 콘텐츠는 모두 원 저작자에게 속하며 Player FM이 아닌 작가가 저작권을 갖습니다. 오디오는 해당 서버에서 직접 스트리밍 됩니다. 구독 버튼을 눌러 Player FM에서 업데이트 현황을 확인하세요. 혹은 다른 팟캐스트 앱에서 URL을 불러오세요.

COVID-19, Ivermectin, a dissolving pacer, clinician well-being, and finerenone are discussed this week.

1 COVID-19

US 'Losing Time' Against Delta Variant, NIH Chief Says https://www.medscape.com/viewarticle/954882

Ivermectin for COVID: How Do We Know What to Believe? https://www.medscape.com/viewarticle/954681

2 Dissolving Pacemaker

Dissolving Pacemaker Impressive in Early Research https://www.medscape.com/viewarticle/954774

3 Clinician Well-being

Global Heart Organizations Unite to Promote Clinician Well-Being https://www.medscape.com/viewarticle/954803

Clinician Well-Being: Addressing Global Needs for Improvements in the Health Care Field A Joint Opinion From the American College of Cardiology, American Heart Association, European Society of Cardiology, and the World Heart Federation https://www.jacc.org/toc/jacc/0/0

From Triple to Quadruple Aim: Care of the Patient Requires Care of the Provider https://www.annfammed.org/content/12/6/573.full

Bullying in Academic Medicine Rife, Underreported https://www.medscape.com/viewarticle/954709

4 Finerenone

FDA Approves Finerenone (Kerendia) for Slowing CKD in Type 2 Diabetes https://www.medscape.com/viewarticle/954606

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

189 에피소드